Join to View Full Profile
1155 Mill StReno, NV 89502
Phone+1 775-982-5638
Fax+1 775-982-5639
Dr. Hardacre is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Hardacre is a Radiation Oncologist based in Reno, NV. He completed his medical degree in 1995 and residency in Radiation Oncology in 2004 at Indiana University School of Medicine. He currently serves as the Chief of Radiation Oncology for the Pennington Cancer Institute and University of Nevada Reno School of Medicine. His area expertise and clinical practice is in Breast Cancer.
Education & Training
Indiana University School of MedicineResidency, Radiation Oncology, 2000 - 2004
Ascension St Vincent Hospital IndianapolisInternship, Transitional Year, 1995 - 1996- Indiana University School of MedicineClass of 1995
Certifications & Licensure
NV State Medical License 2013 - 2027
AL State Medical License 2007 - 2013
IN State Medical License 1996 - 2009
American Board of Radiology Radiation Oncology
Clinical Trials
- RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Publications & Presentations
PubMed
- 42 citationsProstate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.Morgan Tharp, Michael Hardacre, Richard Bennett, W. Terry Jones, David Stuhldreher
Brachytherapy. 2008-07-01 - 32 citationsParthenolide Sensitizes Cells to X-Ray-Induced Cell Killing through Inhibition of NF-κB and Split-Dose RepairMarc S. Mendonca, Helen Chin-Sinex, Jaime Gomez-Millan, Nicholas Datzman, Michael Hardacre
Radiation Research. 2007-12-01 - 169 citationsCutaneous Angiosarcoma Following Breast-conserving Surgery and Radiation: An Analysis of 27 CasesSteven D. Billings, Jesse K. McKenney, Andrew L. Folpe, Michael C Hardacre, Sharon W. Weiss
The American Journal of Surgical Pathology. 2004-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
